This growing reliance on nutraceuticals and dietary supplements is unfolding alongside a rise in lifestyle related health concerns. India is already home to over 101 million people living with diabetes (11.4 per cent), while 35.5 per cent of the population is affected by hypertension, reflecting the scale at which diet-linked risks are shaping public health outcomes. In response, consumers are increasingly turning to supplements, herbal formulations, and functional nutrition products as preventive health solutions.
With more consumers self-prescribing supplements based on digital content, peer recommendations, and wellness trends, the reliance on label claims has become even more pronounced.
The pharmacy shelf and online wellness marketplace have become a battleground of promises. A bottle of multivitamins claims to ‘boost immunity.’ A herbal supplement assures ‘better digestion and detox.’ A protein powder positions itself as “clinically proven for strength and recovery.” For the average Indian consumer, these front-ofpack claims are often the fastest and most trusted route to a purchase decision.
How many of these claims actually hold up to regulatory scrutiny? And more importantly, what does it mean for the future of nutraceutical innovation when the answer is uncomfortable?
That answer is already beginning to emerge from industry-wide data.
Is the problem built into the system?
These patterns point to a deeper structural issue. The compliance failures seen across the nutraceutical and supplement sector are less about individual negligence and more about how the industry has historically approached product development. Regulatory review has typically been a last mile activity, something addressed after a product is formulated, named, and packaged, rather than being woven into the process from the very beginning.
When claims outpace compliance
A comprehensive independent study analysing 5,058 labelling claims across 586 products, 227 brands, and 18 categories found that 33.6 per cent of claims were either non-compliant (21.3 per cent) or lacked independent verification (12.3 per cent). Within nutraceuticals, the risk is often higher given the overlap between food, medicine, and wellness positioning. In effect, nearly one in three claims fails to meet regulatory expectations, with over 50 per cent of health-related claims falling short of standards set by the Food Safety and Standards Authority of India (FSSAI), the Advertising Standards Council of India (ASCI), and the Consumer Protection Act, 2019, while a further portion could not be independently verified.
The categories with the highest noncompliance rates are the ones consumers increasingly rely on for preventive care. Immunity boosters, herbal extracts, protein supplements, omega-3 capsules, and digestive health formulations show some of the most concerning gaps. These are products consumed with a strong expectation of health benefit, and that expectation makes accuracy in labelling even more critical. Claims around ingredients such as ashwagandha for stress reduction, biotin for hair growth, or probiotics for gut health are often marketed with implied therapeutic benefits that may not always meet regulatory thresholds.
The volume of claims printed on each product amplifies this risk considerably. Nutraceutical products often carry dense clusters of functional, clinical, and lifestyle claims on a single label, making internal validation more complex. At that volume, even a well-intentioned review process becomes prone to oversight, inconsistency, and error.
In many cases, a single supplement label carries multiple layered claims spanning performance, immunity, and long-term wellness, increasing the risk of overlap, exaggeration, or non-compliance.
The problem deepens as the industry pushes further into personalised nutrition, bioactive ingredients, and condition-specific formulations, where the science underpinning each claim is more specialised and the regulatory expectations are significantly higher.
Products targeted at fitness enthusiasts, ageing populations, and children require particular scrutiny. Supplements positioned for growth, cognition, or performance often influence long-term consumption habits. Overstated or unsubstantiated claims in these segments carry a higher burden of responsibility, extending beyond compliance into consumer safety and trust.
Stricter enforcement on claims and labelling
Compliant data reflects this increased scrutiny. Nutraceuticals and health supplements are increasingly appearing in regulatory and advertising violation reports, with a large share of breaches linked to exaggerated or unverified health claims. Many of these are withdrawn only after intervention, pointing to a persistent gap between intent and internal validation.
This disconnect is now drawing a stronger regulatory response. Over the past year, India’s regulatory framework for health supplements and nutraceuticals has shifted from passive oversight to active enforcement. FSSAI has moved to curb vague descriptors such as “100 per cent natural” or “clinically proven” without substantiation, while the Food Safety Connect app has opened up consumer-led reporting of labelling violations.
From January 2026, mandatory scientific substantiation of product claims further raises the bar, requiring brands to back every assertion with evidence.
A key challenge lies in navigating the fine line between structure-function claims permitted under nutraceutical regulations and drug-like claims that require clinical validation and approval.
At the same time, evolving policy direction and taxation clarity, including developments such as GST rationalisation for nutraceuticals, are expected to bring greater formalisation and accountability to the sector. In parallel, clearer labelling norms are gaining momentum, especially for products making therapeutic or functional claims.
At the same time, the industry has been actively investing in innovation to align with evolving consumer preferences. The rise of plant-based supplements, clean-label formulations, ayurvedic nutraceuticals, and clinically backed wellness products reflects a clear shift toward more credible and science-led offerings. These developments signal a more conscious approach to product development, where efficacy and transparency are becoming central to brand positioning.
As the nutraceutical market in India continues to expand rapidly, regulatory clarity and standardisation are becoming central to sustaining long-term growth and consumer trust.
The direction is clear. Compliance is now a front-end requirement shaping how nutraceutical products are formulated, positioned, and brought to market.
Where innovation must go next
The nutraceutical industry’s next chapter depends on expanding its definition of innovation. Product development that introduces new ingredients, delivery formats, or health propositions is valuable, but it means little if the claims attached to those products cannot be substantiated with evidence and defended under regulatory scrutiny.
Building compliance into the earliest stages of development, at formulation, during the creation of marketing language, and well before a product reaches print, is the standard the industry must now meet.
In this context, technology is emerging as a critical enabler. AI-powered systems can support faster validation of claims, reduce manual review time, and help ensure alignment with evolving regulatory frameworks. This allows companies to innovate with greater confidence, knowing that product claims are backed by data and can withstand scrutiny across markets.
AI-powered label validation tools like FoLSol® are making this significantly more achievable. What once required hours of manual regulatory cross-checking across multiple frameworks can now be completed in minutes. For exporters managing compliance across 22 or more global markets simultaneously, this kind of infrastructure is a practical necessity. The businesses treating compliance technology as a core investment are the ones best positioned for sustainable, penalty-free growth.
Conclusion
Consumer awareness in India is at an inflection point. Buyers of nutraceuticals and supplements are becoming more discerning, actively evaluating ingredient lists, clinical backing, and the credibility of claims before making a purchase.
At the same time, demand for preventive health solutions continues to grow, making it essential for innovation and credibility to move together. The nutraceutical companies that will define the next decade are those that treat honest, substantiated labelling as a business priority from day one of product development.
Genuine innovation in healthier lifestyles starts with getting the label right.
